UroAlert - GU Oncology Daily

May 25, 2026

Videos

Peer-to-Peer Clinical Conversations

Radioligand Therapy and Patient Selection Criteria for Lu-PSMA-617 - Phillip Koo

Phillip Koo

Phillip Koo discusses practical implementation of lutetium-177 PSMA therapy, covering access, imaging workflows, and monitoring.

Rethinking Recurrence Burden in Low-Grade and Intermediate-Risk NMIBC - Sarah Psutka

Sarah Psutka

Sarah Psutka discusses the burden and management of intermediate-risk non-muscle invasive bladder cancer.

Beyond the Abstracts

Is More Better? Evaluating Neoadjuvant Chemotherapy Cycles Before Surgery for High-Risk Upper Tract Urothelial Carcinoma - Beyond the Abstract

Nivolumab plus Ipilimumab Induce Hyper-Progression in Renal Medullary Carcinoma: How a “Negative” Trial May Save Lives - Beyond the Abstract

Conference Coverage

AUA 2026: Association of Serum Kidney Injury Molecule-1 (KIM-1) with Treatment Response and Survival in Metastatic Renal Cell Carcinoma

AUA 2026: Advanced Prostate Cancer - Doublet Versus Triplet: Who Needs Additional Treatment Intensification for mHSPC?

AUA 2026: Adding Upfront, Perioperative Durvalumab vs Adopting Risk-Adapted Adjuvant Nivolumab? Cost-Effectiveness Analysis of Competing Treatment Strategies for Cisplatin-Eligible MIBC in the Era of Immune Checkpoint Inhibitors

AUA 2026: Detection of Bladder Cancer in Patients with Microscopic Hematuria using Oncuria-Detect, Interim Analysis of an International Prospective Study

AUA 2026: Paradigm 1 - a Multi-Center Phase 1 Study Evaluating the Safety and Clinical Effect of a Novel Microbial Immunotherapeutic (ZH9) in Patients with Relapsed NMIBC – a First Interim Review

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.

Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer.

Impact of Pelvic Lymph Node Dissection on Oncological Outcomes in Patients with Clinically Staged Non-Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Systematic Review - Beyond the Abstract

Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design - Beyond the Abstract

Renal Cancer

Bibliometric study on hotspots and trends of immunotherapy for kidney cancer from 2014 to 2024.

Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma.

CT-Based Renal Artery Caliber Change as a Potential Imaging Marker of Treatment Response in Renal Cell Carcinoma; an Exploratory Imaging Study - Beyond the Abstract

Prostate Cancer

Radioligand Therapy Hormone Combinations and the ENZA-p Trial.

Elective Nodal Radiotherapy in Localized Prostate Cancer: A Meta-Analysis.

Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes.

Frailty and Quality of Life in Low-Income, Uninsured Men with Prostate Cancer.

Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial.

Upper Tract Tumors

Renal function outcomes following endoscopic management of upper tract urothelial carcinoma.

Testicular Cancer

NFL's Alex Singleton and the Testicular Cancer Detection Gap.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC